Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 3 subunit C-like (EIF3CL) is a core protein component of the eukaryotic translation initiation factor 3 (eIF3) complex, a large multiprotein assembly essential for the initiation of protein synthesis in eukaryotic cells. EIF3CL is nearly identical to EIF3C, a closely related paralog. The eIF3 complex binds the 40S ribosomal subunit and acts as a scaffold to recruit other initiation factors and the initiator tRNA, facilitating assembly of the 43S pre-initiation complex. This complex promotes mRNA recruitment and scanning for the AUG start codon, and prevents premature joining of the 60S ribosomal subunit. Additionally, eIF3 components help recycle ribosomal complexes after translation termination and regulate specific subsets of mRNA translation. While dysregulation of eIF3 subunits has been implicated broadly in cancer, EIF3CL itself is primarily recognized for its conserved, essential role in general protein synthesis and has been associated with autism spectrum disorder[1][2][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 3 subunit C-like (EIF3CL).